DD Share Price | DuPont de Nemours, Inc. Stock Analysis & Recommendation

Q: How big is DuPont de Nemours, Inc.?

Market Cap: As of Jun 18, DuPont de Nemours, Inc. has a market capitalization of 28,098.00 million, classifying it as a Large Cap company.Recent Quarterly Performance: For the latest four quarters, DuPont de Nemours, Inc. reported net sales of 12,521.00 million and a net profit of 47.00 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 23,350.00 million and total assets of 36,636.00 million.

Q: What does DuPont de Nemours, Inc. do?

Overview:DuPont de Nemours, Inc. provides technology-based materials, ingredients, and solutions in the Chemicals & Petrochemicals industry and operates within the large-cap market segment.Financial Snapshot:Most recent Net Sales: 3,066 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -548 Million (Quarterly Results - Mar 2025) Market-cap: USD 28,098.00 Million (Large Cap) Key Metrics:P/E: 21.00 Dividend Yield: 191.76% Debt Equity: 0.24 Return on Equity: 5.91% Price to Book: 1.23 Contact Details:Address: 974 Centre Rd Bldg 730, WILMINGTON DE: 19805-1269 Tel: 1 302 7741000 Website: https://www.dupont.com/

Q: Is DuPont de Nemours, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for DuPont de Nemours, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the monthly RSI is also bullish, indicating positive momentum. Bollinger Bands are bullish on both weekly and monthly time frames, supporting the bullish stance. Daily moving averages are bullish, while the weekly KST is bullish, although it is bearish on a monthly basis. Dow Theory shows a mildly bullish trend on both weekly and monthly charts. In terms of performance, DuPont has outperformed the S&P 500 over the past week with a return of 4.91% compared to 1.09%, but it has underperformed in the longer term, with a year-to-date return of 5.99% versus 14.18% for the S&P 500. Overall, the current technical stance is bullish, reflecting a strengthening trend.

Q: Is DuPont de Nemours, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for DuPont de Nemours, Inc. moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, especially in light of its P/E ratio of 21, which is competitive against its peer, which has a P/E of 22.23. Additionally, the EV to EBITDA ratio stands at 10.75, while the industry average is not provided, suggesting a potential value proposition. The Price to Book Value of 1.25 further supports this valuation perspective.In comparison to its peers, DuPont's valuation metrics indicate it may be positioned well within the Chemicals & Petrochemicals industry. Notably, the company has a dividend yield of 188.98%, which is exceptionally high and could appeal to income-focused investors. Over the past year, DuPont has underperformed against the S&P 500, with a return of -6.65% compared to the index's 14.08%, but it has shown stronger performance over the past three years with a return of 49.51% versus the S&P 500's 81.19%. This mixed performance highlights the potential for recovery and growth in the coming periods.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

800.7 k

Shareholding (Dec 2025)

FII

15.61%

Held by 398 FIIs

DII

49.02%

Held by 73 DIIs

Promoter

0.00%

How big is DuPont de Nemours, Inc.?

22-Jun-2025

As of Jun 18, DuPont de Nemours, Inc. has a market capitalization of $28.1 billion, with recent net sales of $12.5 billion and a net profit of $47 million.

View full answer

What does DuPont de Nemours, Inc. do?

22-Jun-2025

DuPont de Nemours, Inc. operates in the Chemicals & Petrochemicals industry, providing technology-based materials and solutions. As of March 2025, it reported net sales of $3.066 billion and a net loss of $548 million, with a market cap of $28.1 billion.

View full answer

Who are in the management team of DuPont de Nemours, Inc.?

22-Jun-2025

As of March 2022, the management team of DuPont de Nemours, Inc. includes Executive Chairman and CEO Edward Breen, Lead Independent Director Alexander Cutler, and Independent Directors Amy Brady, Ruby Chandy, Franklin Clyburn, and Terrence Curtin. They are responsible for the company's strategic direction and governance.

View full answer

Is DuPont de Nemours, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, DuPont de Nemours, Inc. shows a bullish technical trend with positive momentum indicators, having outperformed the S&P 500 in the past week but underperformed year-to-date.

View full answer

Is DuPont de Nemours, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, DuPont de Nemours, Inc. is considered an attractive investment due to its competitive P/E ratio of 21, a high dividend yield of 188.98%, and potential for recovery despite recent underperformance against the S&P 500.

View full answer

Compare DuPont de Nemours, Inc. with Similar Stocks

Eastman Chemical Co.Element Solutions, Inc.Huntsman Corp.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Flat results in Jun 25

NET PROFIT(9M) At USD -49.39 MM has Grown at -104.67%
ROCE(HY) Lowest at 0.31%

Risky -

Mojo Parameters

Stock DNA

Industry

Chemicals & Petrochemicals

Market cap

USD 18,565 Million (Mid Cap)

P/E

14.00

Industry P/E

Dividend Yield

2.75%

Debt Equity

0.18

Return on Equity

9.38%

Price to Book

1.33

Revenue and Profits:

Net Sales:

1,693 Million

(Quarterly Results - Dec 2025)

Net Profit:

-108 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

12.81%

6 Months

48.59%

1 Year

44.89%

2 Years

45.87%

3 Years

61.47%

4 Years

-39.9%

5 Years

43.52%

DuPont de Nemours, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-11.48%

EBIT Growth (5y)

-1.17%

EBIT to Interest (avg)

4.35

Debt to EBITDA (avg)

1.72

Net Debt to Equity (avg)

0.24

Sales to Capital Employed (avg)

0.42

Tax Ratio

90.52%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

78.99%

ROCE (avg)

6.46%

ROE (avg)

6.17%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.33

EV to EBIT

11.71

EV to EBITDA

7.51

EV to Capital Employed

1.28

EV to Sales

1.90

PEG Ratio

2.66

Dividend Yield

2.75%

ROCE (Latest)

10.96%

ROE (Latest)

9.38%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 143 Schemes (35.26%)

Foreign Institutions

Held by 398 Foreign Institutions (15.61%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -44.89% vs -5.68% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -135.06% vs 29.41% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,693.00",
          "val2": "3,072.00",
          "chgp": "-44.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "386.00",
          "val2": "804.00",
          "chgp": "-51.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "61.00",
          "val2": "99.00",
          "chgp": "-38.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-261.00",
          "val2": "-162.00",
          "chgp": "-61.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-108.00",
          "val2": "308.00",
          "chgp": "-135.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.10%",
          "val2": "178.10%",
          "chgp": "-4.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -44.70% vs 2.64% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -87.40% vs 45.97% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,849.00",
          "val2": "12,386.00",
          "chgp": "-44.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,507.00",
          "val2": "3,023.00",
          "chgp": "-50.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "313.00",
          "val2": "366.00",
          "chgp": "-14.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-437.00",
          "val2": "-499.00",
          "chgp": "12.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "98.00",
          "val2": "778.00",
          "chgp": "-87.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.60%",
          "val2": "147.70%",
          "chgp": "-2.21%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

1,693.00

3,072.00

-44.89%

Operating Profit (PBDIT) excl Other Income

386.00

804.00

-51.99%

Interest

61.00

99.00

-38.38%

Exceptional Items

-261.00

-162.00

-61.11%

Consolidate Net Profit

-108.00

308.00

-135.06%

Operating Profit Margin (Excl OI)

134.10%

178.10%

-4.40%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -44.89% vs -5.68% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -135.06% vs 29.41% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

6,849.00

12,386.00

-44.70%

Operating Profit (PBDIT) excl Other Income

1,507.00

3,023.00

-50.15%

Interest

313.00

366.00

-14.48%

Exceptional Items

-437.00

-499.00

12.42%

Consolidate Net Profit

98.00

778.00

-87.40%

Operating Profit Margin (Excl OI)

125.60%

147.70%

-2.21%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -44.70% vs 2.64% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -87.40% vs 45.97% in Dec 2024

All Annual Results

Company CV

About DuPont de Nemours, Inc.

DuPont de Nemours, Inc.

Chemicals & Petrochemicals

DuPont de Nemours, Inc., formerly DowDuPont Inc., provides technology-based materials, ingredients and solutions. The Company offers its products and solutions across four businesses: Electronics and Imaging, Nutrition and Biosciences, Safety and Construction, and Transportation and Industrial. It offers products under various brands, such as Kevlar, Nomex, Tyvek, Sorona, Danisco, Corian, GREAT STUFF and Styrofoam. Its product lines include adhesives, animal nutrition, biomaterials, clean technologies, construction materials, consumer products, electronic solutions, dietary supplements, water solution, microbial control solutions, industrial enzymes and bioactives, packaging materials and solutions, and medical devices and materials. It provides solutions to a range of markets, including automotive, building and construction, energy, government and public sector, military, law enforcement, emergency response, packaging and printing, and safety and protection industries.

Company Coordinates

Company Details

974 Centre Rd Bldg 730 , WILMINGTON DE : 19805-1269

Tel: 1 302 7741000

https://www.dupont.com/

Registrar Details